UNILATERAL THYROIDECTOMY
ProcedureOther names: TOTAL THYROIDECTOMY
NCT Number: NCT04500925
Background After diagnosing well-differentiated thyroid cancer (WDTC), careful assessment of the risk for disease-specific recurrence is essential for deciding between partial (low risk) and completion (high risk) thyroidectomies. Patients' preoperatively determined risk levels are re-stratified according to surgical and final histopathological findings. The American Thyroid Association 2015 guidelines suggest that patients with WDTC between 1-4 cm in size and without suspicious features may be suitable candidates for partial thyroidectomy. The incidence and clinical implications of high-risk features discovered postoperatively in patients with preoperatively determined low-risk WDTC have not been previously reported.
Methods All thyroidectomies performed between 2006-2018 in the Tel Aviv Sourasky Medical Center were included. Pre- and postoperative risk stratifications were performed, and the rate of completion thyroidectomy was determined. Patients with 1-4 cm WDTC without evidence of positive cervical lymph nodes, invasion to adjacent structures, or high-risk cytology were considered at low risk for disease-specific recurrence and therefore suitable for lobectomy.
Looking for future studies?
Notify Me38 year–61 year
All sexes
Observational
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: TOTAL THYROIDECTOMY
Time frame: 2006-2018
WDTC recurrence
Tel-Aviv Sourasky Medical Center
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07652450
Adenocarcinoma, Adenocarcinoma, Follicular
Minya, Minya Governorate, Egypt
View Trial DetailsNCT07659717
Adenocarcinoma, Adenocarcinoma, Papillary
Palermo, Sicily, Italy
View Trial DetailsNCT06235814
Adenocarcinoma, Adenocarcinoma, Papillary
Los Angeles, California, United States
View Trial DetailsNCT06439745
Adenocarcinoma, Adenocarcinoma, Papillary
View Trial Details